Wolverine Trading, LLC Novavax Inc Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Novavax Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 45,763 shares of NVAX stock, worth $389,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,763

Previous 84,994 46.16%

Holding current value

$389,443

Previous $1.08 Million 46.38%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $420,164 - $671,242	-39,231 Reduced 46.16%	45,763 $577,000
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $330,626 - $1.78 Million	84,994 New	84,994 $1.08 Million
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $417,256 - $865,910	-11,501 Reduced 31.25%	25,302 $1.31 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $507,076 - $1.04 Million	7,272 Added 24.62%	36,803 $2.75 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $772,374 - $1.25 Million	-5,740 Reduced 16.27%	29,531 $4.57 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $1.07 Million - $1.63 Million	-6,025 Reduced 14.59%	35,271 $7.18 Million
Q2 2021 Aug 06, 2021	BUY	$121.0 - $257.67 $1.52 Million - $3.24 Million	12,590 Added 43.86%	41,296 $8.63 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $362,439 - $1.03 Million	-3,208 Reduced 10.05%	28,706 $4.98 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $661,573 - $1.17 Million	8,402 Added 35.73%	31,914 $3.8 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $519,458 - $1.17 Million	6,539 Added 38.53%	23,512 $2.54 Million
Q2 2020 Aug 13, 2020	SELL	$13.86 - $83.61 $53,846 - $324,824	-3,885 Reduced 18.63%	16,973 $1.42 Million
Q1 2020 May 11, 2020	BUY	$3.93 - $16.0 $81,971 - $333,728	20,858 New	20,858 $298,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Novavax Inc Transaction History